Author

L. Marignol

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. R. Anderson· 1 shared B. Desai· 1 shared C. O'Farrelly· 1 shared J. O'Sullivan· 1 shared J. S. Brown· 1 shared J. West· 1 shared K. A. Luddy· 1 shared M. Robertson-Tessi· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. Anderson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Evolutionary double-bind treatment using radiotherapy and NK cell-based immunotherapy in prostate cancer

K. A. Luddy, J. West, M. Robertson-Tessi, B. Desai, T. M. Burrsell, S. Barrett, J. O'Sullivan, L. Marignol, R. Gatenby, J. S. Brown, A. R. Anderson, C. O'Farrelly

This study combines radiotherapy and NK cell immunotherapy to exploit an evolutionary double-bind strategy in prostate cancer, showing that RT-resistant cells become more vulnerable to NK cell killing.

bioRxiv · Mar 11, 2024 · PreprintCancer Biology